Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine

Progress in Neurobiology

Volumn 82, Issue 1, 2007, Pages 1-10

  Shi, Yu Liang ^a   Li, Mu Feng ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Apoptosis; Botulism; Ca2+; K+ channel; Presynaptic blocker; SNARE protein; Toosendanin

Indexed keywords

BOTULINUM TOXIN; POTASSIUM CHANNEL; SNARE PROTEIN; TOOSENDANIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; APOPTOSIS; BOTULISM; CALCIUM CONDUCTANCE; CALCIUM TRANSPORT; CANCER CELL; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; CHINESE; ENZYME SUBSTRATE; EXCITABILITY; HUMAN; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SYNAPTIC TRANSMISSION; TRADITIONAL MEDICINE;

ANIMALS; APOPTOSIS; BOTULISM; CALCIUM CHANNELS; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; SYNAPTIC TRANSMISSION;

EID: 34248208151     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.02.002     Document Type: Review

References (79)

1. Bensoussan A., Talley N.J., Hing M., Menziesm R., Guo A., and Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 280 (1998) 1585-1589
2. Blaustein R.O., Germann W.J., Finkelstein A., and DasGupta B.R. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett. 226 (1987) 115-120
3. Carpinella M.C., Defago M.T., Valladares G., and Palacios S.M. Antifeedant and insecticide properties of a limonoid from Melia azedarach (Meliaceae) with potential use for pest management. J. Agric. Food Chem. 51 (2003) 369-374
4. Chen W.Y., and Shi Y.L. The morphological changes induced by toosendanin on NG108-15 cells and SK-N-SH cells. Chin. J. Anat. 23 (2000) 1-5
5. Chen W.Y., Yin P.B., Ye W.L., and Shi Y.L. Toosendanin-induced change of dopamine level detected by microdialysis in vivo at rat striatum. Chin. Sci. Bull. 44 (1999) 1106-1110
6. Cheng J.T. Review: drug therapy in Chinese traditional medicine. J. Clin. Pharmacol. 40 (2000) 445-450
7. Chiu S.F. Recent advances in research on botanical insecticides in China. In: Arnason J.T., Philogene B.J.R., and Morand P. (Eds). Insecticides of Plant Origin. Am. Chem. Soc. Symp. Ser. vol. 387 (1989), American Chemical Society, Washington, DC 69-77
8. Clark A.W., Hurlbut W.P., and Mauro A. Changes in the fine structure of neuromuscular junction of the frog caused by black widow spider venom. J. Cell. Biol. 52 (1972) 1-14
9. Cui Z.J., and He X.H. The pre-synaptic blocker toosendanin does not inhibit secretion in exocrine cells. World J. Gastroenterol. 8 (2002) 918-922
10. 2+ currents in mouse and frog motor nerve terminals. Neurosci. Res. 41 (2001) 243-249
11. Donovan J.J., and Middlebrook J.L. Ion-conducting channels produced by botulinum toxin in planar lipid membranes. Biochemistry 25 (1986) 2872-2876
12. Gao X.D., Tang S.B., Lu J., and Shi Y.L. Effects of toosendanin on electric and mechanical properties of guinea pig papillary muscles. Acta Pharmacol. Sin. 15 (1994) 147-151
13. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 12 (1994) 53-63
14. Hajnoczky G., Davies E., and Madesh M. Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 445-454
15. Hoch D.H., Romero-Mira M., Ehrlich B.E., Finkelstein A., and Dasgupta B.R. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 1692-1696
16. Hu Q., Huang F.S., and Shi Y.L. Inhibition of toosendanin on the delayed rectifier potassium current in neuroblastoma × glioma NG108-15 cells. Brain Res. 751 (1997) 47-53
17. 3H] noradrenaline release from rat hippocampal slices. Nat. Toxins 4 (1996) 92-95
18. Huang S.K., Song X.E., and Shi Y.L. Effects of toosendanin on the fine structure of the mouse neuromuscular junction. Acta Physiol. Sin. 32 (1980) 385-390
19. Katz B., and Miledi R. Transmitter leakage from motor nerve endings. Proc. R. Soc. Lond. B Biol. Sci. 196 (1977) 59-72
20. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228 (1985) 1049-1055
21. Koriazova L.K., and Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10 (2003) 13-18
22. Li M., and Song J.Z. Chinaberry seeds combined with synthesized therapeutics saved patients from botulism. Chin. J. Crit. Care. Med. 23 (2003) 718
23. 2+ channels in neonatal rat ventricular cells. Eur. J. Pharmacol. 501 (2004) 71-78
24. 2+ channels in NG108-15 cells. Toxicon 45 (2005) 53-60
25. Li M.F., and Shi Y.L. Toosendanin inhibits pore formation of botulinum toxin type A at PC12 cell membrane. Acta Pharmacol. Sin. 27 (2006) 66-70
26. 2+ current in NG108-15 cells via L-type channels. Neurosci. Res. 49 (2004) 197-203
27. Li P.Z., and Sun G.Z. Antibotulismic effect of toosendanin to botulinum toxins on neuromuscular preparations of mice. Acta Physiol. Sin. 35 (1983) 480-483
28. Li P.Z., Zhou J., Miao W.Y., Ding F.H., Meng J.Y., Jia G.R., Li J.F., Ye H.J., He X.Y., Chen M.Y., and Huang Z.M. Therapeutic effect of toosendanin on animal botulism. Chin. Tradit. Herb. Drugs 13 (1982) 28-30
29. Mallart A. Presynaptic currents in frog motor endings. Pflugers. Arch. 400 (1984) 8-13
30. Nattson M., and Kater S. Calcium regulation of neurite elongation and growth cone motility. J. Neurosci. Res. 7 (1987) 4034-4043
31. Nattson M., Taylor-Hunter A., and Skater S. Neurite outgrowth in individual neurons of a neuronal population is differentially regulated by calcium and cyclic AMP. J. Neurosci. 8 (1988) 1704-1711
32. Randic M., and Straughan D.W. Antidromic activity in the rat phrenic nerve-diaphragm preparation. J. Physiol. 173 (1964) 130-148
33. Roden D.M., Balser J.R., George Jr. A.L., and Anderson M.E. Cardiac ion channels. Annu. Rev. Physiol. 64 (2002) 431-475
34. Sathyamoorthy V., and DasGupta B.R. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E. J. Biol. Chem. 260 (1985) 10461-10466
35. 3-toosendanin in rat cerebral cortex homogenate. Acta Physiol. Sin. 46 (1994) 546-552
36. Sheridan R.E. Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon 36 (1998) 703-717
37. Shi Y.L. Abolishment of non-quantal release of acetylcholine from the mouse phrenic nerve ending by toosendanin. Jpn. J. Physiol. 33 (1986) 677-680
38. Shi Y.L. Toosendanin, a new presynaptic blocker. In: Chen Y.C., and Yuan S.L. (Eds). Study and Utility of Toxins (1988), Science Press, Beijing 192-206
39. Shi Y.L. Chinaberry and toosendanin (in Chinese). In: Liu D.Y. (Ed). Exploitation and Utility of Biotoxins (2007), Chemical Industrial Press (Chapter 19)
40. Shi Y.L., and Chen W.Y. Effect of Toosendanin on acetylcholine release from rat brain, a microdialysis study. Brain Res. 850 (1999) 173-178
41. 2+ conductance increase in neuroblastoma × glioma hybrid cells. Chin. Sci. Bull. 38 (1993) 1489-1493
42. + current in guinea pig ventricular myocytes. CAPS News Commu. 11 Suppl. 1 (1992) 44-45
43. Shi Y.L., and Sun L.Q. Selective binding of toosendanin to synaptosome fraction from rat brain. Acta Physiol. Sin. 34 (1982) 211-216
44. Shi Y.L., and Tang M.Z. Cell death and apoptosis-induced effect of toosendnin. Chin. J Neurosci. 20 (2004) 461-465
45. Shi Y.L., Wang W.P., Liao C.Y., and Chiu S.H. Effect of toosendanin on the sensory inputs of chemoreceptors in the armyworm larvae (Mythimne Separata). Atca Entomal. Sin. 29 (1986) 233-239
46. Shi Y.L., Wang W.P., and Xu K. Electrophysiological analysis on the presynaptic blocking effects of toosendanin on neuromuscular transmission. Acta Physiol. Sin. 33 (1981) 259-265
47. Shi Y.L., Wang W.P., Yan S.Q., and Xu K. Effects of calcium ions and nerve impulses on changes in miniature end-plate potential frequency produced by toosendanin. Acta Physiol. Sin. 34 (1982) 304-309
48. Shi Y.L., and Wang Z.F. Cure of experimental botulism and antibotulismic effect of toosendanin. Acta Pharmacol. Sin. 25 (2004) 839-848
49. 2+ concentration. Prog. Biochem. Biophys. 34 2 (2007) 132-137
50. Shi Y.L., Wei N.S., Yang Y.Q., and Wang Z.X. Toosendanin-a presynaptic neuromuscular blocking agent. Acta Physiol. Sin. 32 (1980) 293-297
51. Shi Y.L., and Xu K. Antibotulismic effect of toosendanin. Chin. Sci. Bull. 28 (1983) 885-887
52. Shi Y.L., and Xu K. Anti-botulismic effect of toosendanin and its facilitatory action on miniature end-plate potentials. Jpn. J. Physiol. 33 (1983) 677-680
53. 2+ on onset of toosendanin paralysis of isolated neuromuscular preparations of rats. Acta Physiol. Sin. 33 (1981) 141-146
54. Shu G.X., and Liang X.T. A correction of the structure of Chuanliansu. Acta Chim. Sin. 38 (1980) 196-198
55. Simpson L.L. Botulinum Neurotoxin and Tetanus Toxin (1989), Academy Press, San Diego
56. (3)-linked mitochondria calcium signals. EMBO J. 18 (1999) 6349-6361
57. Tang M.Z., Wang Z.F., and Shi Y.L. Toosendanin induces outgrowth of neuronal processes and apoptosis in PC12 cells. Neurosci. Res. 45 (2003) 225-231
58. Tang M.Z., Wang Z.F., and Shi Y.L. Involvement of cytochrome c release and caspase activation in toosendanin-induced apoptosis of PC12 cells. Toxicology 201 (2004) 31-38
59. Tang W., and Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine (1992), Springer, Heidelberg
60. Vyskocil F., Nikolsky E., and Edwards C. An non-quantal release of acetylcholine at the mouse neuromuscular junction. Neuroscience 9 (1983) 429-435
61. + channel in hippocampal neurons by toosendanin. Neuroscience 104 (2001) 41-47
62. Wang Z.F., and Shi Y.L. Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker. Neurosci. Res. 40 (2001) 211-215
63. Wang Z.F., and Shi Y.L. Toosendnin-induced inhibition of small-conductance calcium-activated potassium channels in CA1 pyramidal neurons of rat hippocampus. Neurosci. Lett. 30 (2001) 313-316
64. Wang Y.B., and Wen Y.X. A comprehensive report on clinic ascarid anthelminthic therepeutic effect of toosendanin pills. J. Tradit. Chin. Med. 262 (1959) 46-49
65. Xiong C.S. Effect of toosendanin on the ultrastructural of the rat neuromuscular junction. Yao Xue Xue Bao 17 (1982) 407-412
66. Xiong C.S. The interaction between toosendanin and botulinum toxin at the neuromuscular junction, an ultrastructural observation. Yao Xue Xue Bao 20 (1985) 495-499
67. 2+ channels. Acta Pharmacol. Sin. 25 (2004) 597-601
68. Xu T.H., Shi Y.L., Ren X.M., and Zhou J.Y. Inhibition of glutamate release from rat cerebral synaptosomes by a prejunctional blocker toosendanin. Chin. J. Pharmacol. Toxicol. 18 (2004) 321-326
69. Xu Y.F., and Shi Y.L. Action of toosendanin on the membrane current of motor nerve terminals. Brain Res. 631 (1993) 46-50
70. Yu J.C., Min Z.D., and Ip N.Y. Melia toosendan regulates PC12 Cell differentiation via the activation of protein kinase A and extracellular signal-regulated kinases. Neurosignals 13 (2004) 248-257
71. Zhang X., Wang X.L., and Feng J.T. An innocuous insecticide, toosendanin. Acta Northwe. Uni. Agricult. Sin. 21 (1993) 1-5
72. Zhang B., Wang Z.F., Tang M.Z., and Shi Y.L. Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from Chinese traditional medicine. Invest. New Drugs 23 (2005) 547-553
73. Zhao W.Q., Feng H., Bennett P., and Ng K.T. Inhibition of intermediate-term memory following passive avoidance training in neonate chicks by a presynaptic cholinergic blocker. Neurobiol. Learn Mem. 67 (1997) 207-213
74. Zhong C.C., Hsie T.H., Chen S.F., and Liang H.T. The structure of Chuanliansu. Acta Chem. Sin. 33 (1975) 35-47
75. Zhou J.Y., and Shi Y.L. Inhibition of botulinum toxin's association with rat brain synaptosomes by toosendanin, an antibotulismic triterpenoid. Neural Regen. Res. 1 6 (2006) 489-492
76. Zhou J.Y., Wang Z.F., Ren X.M., Tang M.Z., and Shi Y.L. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin. FEBS Lett. 555 (2003) 375-379
77. Zhu Y.P., and Woerdenbag H.J. Traditional Chinese herbal medicine. Pharm. World Sci. 17 (1995) 103-112
78. Zou J. A study on pharmacokinetics of toosendanin. Chin. Tradit. Herb. Drugs 13 (1982) 24-26
79. Zou J., Miao W.Y., Ding F.H., Meng J.Y., Ye H.J., Jia G.R., He X.Y., Sun G.Z., and Li P.Z. The effect of toosendanin on monkey botulism. J. Tridit. Chin. Med. 5 (1985) 29-30